Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Cardiovascular diseases

STPs encouraged to involve pharmacies in coordinated drive to cut heart attacks and strokes

An analysis presented at Public Health England’s annual conference suggests that if all patients with high blood pressure were identified and treated optimally, it could prevent up to 9,710 heart attacks and 14,500 strokes, saving the NHS up to £274m over three years.

GP takes blood pressure of patient

Source: Shutterstock.com

More access to blood pressure testing in community and workplace settings is expected as part of the drive

Public Health England (PHE) and NHS England have launched a drive to improve detection and treatment of risk factors for cardiovascular disease (CVD), including more blood pressure testing and treatment in pharmacies and increasing update of NHS Health Checks.

Some 5.5 million people in England have undiagnosed high blood pressure and nearly half a million have undiagnosed atrial fibrillation (AF).

On 12 September, an analysis presented at Public Health England’s annual conference in Coventry suggests that if all patients with high blood pressure were identified and treated optimally, it could prevent up to 9,710 heart attacks and 14,500 strokes, saving the NHS up to £274m over three years.

Similarly, identification and optimal treatment of AF patients could avoid 14,220 strokes, saving the NHS £241m over the same timescale.

Public Health England and NHS England have written to all 44 sustainability and transformation partnerships (STPs) urging them to take coordinated action to improve prevention, diagnosis and treatment of high blood pressure and AF. They provided STPs data on the likely prevalence of undiagnosed and untreated hypertension and AF in their areas to highlight the opportunity this presents for prevention.

The majority of STPs have identified prevention of CVD as a priority and are being encouraged to drive improvements through the NHS Right Care programme in partnerships that support widespread implementation of initiatives such as healthy workforce schemes, active transport plans, the Active 10 app (which tracks brisk walking) and smoking cessation programmes.

More testing and treatment in pharmacies, increasing uptake of NHS Health Check, more self-monitoring, and more access to blood pressure testing in community and workplace settings are expected.

Duncan Selbie, chief executive of PHE, told the conference: “High blood pressure is the invisible killer. We want people to be as familiar with their blood pressure numbers as they are with their credit card PIN or their height.”

He added: “Scaling up CVD prevention locally is a major part of reducing the overall burden on individuals, families and the NHS.”

Some areas across the country have already implemented these approaches. In Lambeth and Southwark, pharmacists were commissioned to manage blood pressure and AF, which resulted in an estimated 45 strokes being averted over a 15-month period.

Meanwhile, in West Hampshire, a mix of GP education, diagnostic devices for AF and pharmacist-run anticoagulation services resulted in an estimated 52 strokes being averted in 20 months.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203580

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Essentials of Economic Evaluation in Healthcare

    Essentials of Economic Evaluation in Healthcare

    An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.

    £33.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £81.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • GP takes blood pressure of patient

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.